Article Figures & Data
Figures
- Figure 1.
Summary of studies in the literature examining 24-h albumin excretion in mouse models of diabetes (#, reference number). For each study, a pair of bars represent mean ± SE. On the left, 24-hr albumin excretion in the diabetic cohort; on the right, the nondiabetic cohort. From left to right are albuminuria in C57BL/6 mice treated with multiple low-dose streptozotocin (STZ); C57BL6 high-dose STZ; C57BL6 db/db mice, a model of type 2 diabetes; four studies measuring albuminuria in the C57BLKS db/db strain show generally higher albuminuria; a single study examining 24-h albuminuria in the KK-Ay strain shows robust albuminuria.
Tables
Mouse Model (Reference No.) Strains Reported (Reference No.) DiabeticType Advantages Disadvantages Streptozotocin (71,81,146,228–232) C57BL/6J, C57BLKS, Balb/c, ICR, DBA2, ROP Type 1 Well established, reproducible timing; may be established in strains both resistant and susceptible to DN Potential for nonspecific toxicity; strain-dependent dosing necessary; biohazard: potential mutagen Encephalomyocarditis virus D variant (153,233,234) DBA, Balb-C Type 1 May reproduce viral causes of type 1 diabetes in humans; DBA may be prone to DN Potential for nonspecific renal effects; strain-dependent dosing necessary; biohazard; not widely studied; renal functional effects not characterized Ins2 Akita (84,88,89) C57BL/6, C3H Type 1 Commercially available (JAX); autosomal dominant mutation Presently only C57BL/6 commercially available; C57BL/6 relatively resistant to nephropathy; hyper-glycemia in females is mild NOD (101,102,235,236) Inbred line derived from ICR (outbred line) Type 1 Spontaneous development of β-cell failure may mimic pathophysiology of disease in humans (99); commercially available Unpredictable timing of development of diabetes; no appropriate control strain; needs insulin therapy to survive long periods; multigenic-cause diabetes precludes easy intercrosses Db/db (22,134) C57BL/6, C57BLKS, DBA, FVB (129), CBA (237) Type 2 Available on multiple strains; commercially available Infertile; autosomal recessive; mutation in leptin receptor is a very rare cause of obesity and type 2 diabetes in humans Ob/ob (21) C57BL/6 (238), FVB/N (238), DBA2 (239,240) Type 2 Exists on diverse inbred strains; nephropathy uncharacterized; commercially available Infertility—can be circumvented with leptin; autosomal recessive; nephropathy uncharacterized; mutation of leptin is a very rare cause of obesity and type 2 diabetes in humans Agouti (Ay) KK (170,241,242), C57BL (243), C3H (243), FVB (244) Type 2 KK strain is susceptible to renal injury with significant albuminuria; autosomal dominant; commercially available Hyperglycemia moderate in males more than in females; onset of diabetes is not well defined; nephropathy may not be robust in strains other than KK High-fat diet (112) C57BL/6 is main susceptible strain (245) Type 2 Onset can be determined by the investigator Only C57BL/6 reported as susceptible; hyperglycemia not prominent ↵a DN, diabetic nephropathy.
Mouse Models of Diabetic Nephropathy
Jump to section
- Article
- Abstract
- Working Definition of DN
- Characterization of DN in Mice
- Assessment of Hyperglycemia in Mice
- Assessment of Renal Function in Mice
- Models of Type 1 Diabetes
- Mouse Models of Type 2 Diabetes
- Inbred Mice: Strain Dependence of DN
- Monogenic Mutations and Transgenic Mice
- Conclusions
- Acknowledgments
- References
- Figures & Data Supps
- Info & Metrics
- View PDF
More in this TOC Section
Cited By...
- Drug Testing for Residual Progression of Diabetic Kidney Disease in Mice Beyond Therapy with Metformin, Ramipril, and Empagliflozin
- Systematic review and meta-analysis of mouse models of diabetes-associated ulcers
- Paternal multigenerational exposure to an obesogenic diet drives epigenetic predisposition to metabolic disorders
- Changes in excitability and ion channel expression in neurons of the major pelvic ganglion in female type II diabetic mice
- Signal integration at the PI3K-p85-XBP1 hub endows coagulation protease activated protein C with insulin-like function
- Effects of insulin and the glucagon-like peptide 1 receptor agonist liraglutide on the kidney proteome in db/db mice
- Glomerular Endothelial Mitochondrial Dysfunction Is Essential and Characteristic of Diabetic Kidney Disease Susceptibility
- Comparison of Glomerular and Podocyte mRNA Profiles in Streptozotocin-Induced Diabetes
- Low-Dose IL-17 Therapy Prevents and Reverses Diabetic Nephropathy, Metabolic Syndrome, and Associated Organ Fibrosis
- Four-and-a-Half LIM Domains Protein 2 Is a Coactivator of Wnt Signaling in Diabetic Kidney Disease
- Diabetes Induces Aberrant DNA Methylation in the Proximal Tubules of the Kidney
- Albumin stimulates renal tubular inflammation through an HSP70-TLR4 axis in mice with early diabetic nephropathy
- Vascular Endothelial Growth Factor-A165b Is Protective and Restores Endothelial Glycocalyx in Diabetic Nephropathy
- Renoprotective effects of combined SGLT2 and ACE inhibitor therapy in diabetic Dahl S rats
- Progressive Renal Decline: The New Paradigm of Diabetic Nephropathy in Type 1 Diabetes
- Endogenous Fructose Production and Fructokinase Activation Mediate Renal Injury in Diabetic Nephropathy
- Loss of the Podocyte-Expressed Transcription Factor Tcf21/Pod1 Results in Podocyte Differentiation Defects and FSGS
- CD73-Dependent Generation of Adenosine and Endothelial Adora2b Signaling Attenuate Diabetic Nephropathy
- Knockdown of Glyoxalase 1 Mimics Diabetic Nephropathy in Nondiabetic Mice
- Phlorizin Pretreatment Reduces Acute Renal Toxicity in a Mouse Model for Diabetic Nephropathy
- A Role for the Endothelium in Vascular Calcification
- Celecoxib modifies glomerular basement membrane, mesangium and podocytes in OVE26 mice, but ibuprofen is more detrimental
- Direct Evidence for Intrarenal Chymase-Dependent Angiotensin II Formation on the Diabetic Renal Microvasculature
- A Transcriptional Blueprint for Human and Murine Diabetic Kidney Disease
- eNOS Deficiency Predisposes Podocytes to Injury in Diabetes
- Intrarenal Dopamine Inhibits Progression of Diabetic Nephropathy
- Transgenerational Glucose Intolerance With Igf2/H19 Epigenetic Alterations in Mouse Islet Induced by Intrauterine Hyperglycemia
- Heparanase Is Essential for the Development of Diabetic Nephropathy in Mice
- Arginase-2 Mediates Diabetic Renal Injury
- Knockout of Toll-Like Receptor-2 Attenuates Both the Proinflammatory State of Diabetes and Incipient Diabetic Nephropathy
- Esculetin induced changes in Mmp13 and Bmp6 gene expression and histone H3 modifications attenuate development of glomerulosclerosis in diabetic rats
- Thyroid hormone ameliorates diabetic nephropathy in a mouse model of type II diabetes
- Activation of Vascular Bone Morphogenetic Protein Signaling in Diabetes Mellitus
- The Protective Role of Smad7 in Diabetic Kidney Disease: Mechanism and Therapeutic Potential
- Antiatherosclerotic and Renoprotective Effects of Ebselen in the Diabetic Apolipoprotein E/GPx1-Double Knockout Mouse
- BTBR Ob/Ob Mutant Mice Model Progressive Diabetic Nephropathy
- Inhibition or Deletion of Soluble Epoxide Hydrolase Prevents Hyperglycemia, Promotes Insulin Secretion, and Reduces Islet Apoptosis
- Deletion of the Receptor for Advanced Glycation End Products Reduces Glomerulosclerosis and Preserves Renal Function in the Diabetic OVE26 Mouse
- Mouse Models of Diabetic Nephropathy
- Vasohibin-1, a Negative Feedback Regulator of Angiogenesis, Ameliorates Renal Alterations in a Mouse Model of Diabetic Nephropathy
- Effect of the Monocyte Chemoattractant Protein-1/CC Chemokine Receptor 2 System on Nephrin Expression in Streptozotocin-Treated Mice and Human Cultured Podocytes
- Activation of the Succinate Receptor GPR91 in Macula Densa Cells Causes Renin Release
- The Use of Animal Models in the Study of Diabetes Mellitus
- Enhanced Expression of Janus Kinase-Signal Transducer and Activator of Transcription Pathway Members in Human Diabetic Nephropathy
- Combination therapy with AT1 blocker and vitamin D analog markedly ameliorates diabetic nephropathy: Blockade of compensatory renin increase
- Overexpression of Calmodulin in Pancreatic {beta} Cells Induces Diabetic Nephropathy
- From Fibrosis to Sclerosis: Mechanisms of Glomerulosclerosis in Diabetic Nephropathy
- Long-term hyperglucagonaemia induces early metabolic and renal phenotypes of Type 2 diabetes in mice
- Overexpression of Angiotensinogen Increases Tubular Apoptosis in Diabetes
- Can rodent models of diabetic kidney disease clarify the significance of early hyperfiltration?: recognizing clinical and experimental uncertainties
- Thrombospondin-1 Is an Endogenous Activator of TGF-{beta} in Experimental Diabetic Nephropathy In Vivo
- L-Carnosine, a Substrate of Carnosinase-1, Influences Glucose Metabolism
- The Vascular Ectonucleotidase ENTPD1 Is a Novel Renoprotective Factor in Diabetic Nephropathy
- Targeting glucagon receptor signalling in treating metabolic syndrome and renal injury in Type 2 diabetes: theory versus promise
- Renal Fibrosis and Glomerulosclerosis in a New Mouse Model of Diabetic Nephropathy and Its Regression by Bone Morphogenic Protein-7 and Advanced Glycation End Product Inhibitors
- Interstitial Vascular Rarefaction and Reduced VEGF-A Expression in Human Diabetic Nephropathy
- Recipes for Creating Animal Models of Diabetic Cardiovascular Disease
- Diabetic Endothelial Nitric Oxide Synthase Knockout Mice Develop Advanced Diabetic Nephropathy
- A Sensitized Screen of N-ethyl-N-nitrosourea-Mutagenized Mice Identifies Dominant Mutants Predisposed to Diabetic Nephropathy
- Poly(ADP-Ribose) Polymerase Inhibitors Ameliorate Nephropathy of Type 2 Diabetic Leprdb/db Mice
- Endothelial Nitric Oxide Synthase Deficiency Produces Accelerated Nephropathy in Diabetic Mice
- Heme Oxygenase-2 Deficiency Contributes to Diabetes-Mediated Increase in Superoxide Anion and Renal Dysfunction
- Frontiers in Diabetic Nephropathy: Can We Predict Who Will Get Sick?
- Leukocyte Recruitment and Vascular Injury in Diabetic Nephropathy
- Glucose-Induced Reactive Oxygen Species Cause Apoptosis of Podocytes and Podocyte Depletion at the Onset of Diabetic Nephropathy
- Activation of G{alpha}q-Coupled Signaling Pathways in Glomerular Podocytes Promotes Renal Injury
- Antiangiogenic Endostatin Peptide Ameliorates Renal Alterations in the Early Stage of a Type 1 Diabetic Nephropathy Model
- Characterization of Susceptibility of Inbred Mouse Strains to Diabetic Nephropathy
- Accelerated Glucose Intolerance, Nephropathy, and Atherosclerosis in Prostaglandin D2 Synthase Knock-out Mice